Advertisement

If you'd invested in: Huntsworth and Vectura

After a difficult few years, media group Huntsworth has restructured and seen its share price double.

If only...

889_Good

Huntsworth (LSE: HNT) is a global media group providing marketing and medical communications services to healthcare clients. After a difficult few years following a major restructuring that saw it increasing its focus on the healthcare sector, the firm's shares have doubled over the past 12 months. Earlier this month Huntsworth reported solid 2017 results, during which sales rose by 9% to £197m, while pre-tax profit rocketed 54% higher to £24.4m. Free cash flow also increased, from £2.9m to £20.7m, giving support for a 15% hike in the total dividend.

Be glad you didn't...

889_Bad

Vectura Group (LSE: VEC) develops inhaled therapies for respiratory diseases. In the past year the firm has suffered blows from the US Food and Drug Administration (FDA). Vectura is working with Hikma Pharmaceuticals on developing a generic replacement for rival GlaxoSmithKline's Advair asthma treatment, but the FDA withheld approval for the product last May. A launch is now unlikely to happen before 2020. This month Vectura also announced that annual losses grew from £40.1m in 2016 to £102.2m last year, after it wrote down the value of past acquisitions.

Advertisement
Advertisement

Recommended

Share tips of the week
Share tips

Share tips of the week

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
17 Jan 2020
How the fear of death affects our investment processes
Investment strategy

How the fear of death affects our investment processes

Many of our investment decisions are driven by one simple fact: the knowledge that, one day, we will be dead. Here, in an extract from his new book, J…
2 Jan 2020
Share tips: eight stocks that should deliver robust returns
Share tips

Share tips: eight stocks that should deliver robust returns

Ryan Ermey of US publication Kiplinger’s Personal Finance chooses his favourite stocks for the next decade, which should be able to grow for years.
28 Dec 2019
The good investments of the 2010s – and the bad
Stockmarkets

The good investments of the 2010s – and the bad

John Stepek takes a look back on which investments did well and which did badly in the decade that’s about to come to an end.
26 Dec 2019

Most Popular

Eagle Lightweight GT: the reincarnation of the E-type Jag
Toys and gadgets

Eagle Lightweight GT: the reincarnation of the E-type Jag

Jaguar’s classic E-type sports car has been reinvented for the modern age. The result – the Eagle Lightweight GT – is a thing of beauty.
7 Aug 2020
Platinum: the precious metal that looks set to play catch-up with silver and gold
Silver and other precious metals

Platinum: the precious metal that looks set to play catch-up with silver and gold

Gold and silver continue to soar, but there's still time to get in. And there's another precious metal that looks set to go on a bull run too, says Jo…
7 Aug 2020
UK house prices hit a new record high – can it last?
House prices

UK house prices hit a new record high – can it last?

Despite the pandemic, UK house prices have hit a new high. John Stepek looks at what’s driving the surge in prices, and what it means for house prices…
7 Aug 2020